If you would like to learn more about future focusIR related events and roundtables, please submit your details here

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksWalker Crips Regulatory News (WCW)

  • This share is currently suspended. It was suspended at a price of 13.50
  • There is currently no data for WCW

Director/PDMR Shareholding

27 Nov 2024 07:30

RNS Number : 8398N
Walker Crips Group plc
27 November 2024
 

27 November 2024

 

Walker Crips Group plc

 

("Walker Crips" or the "Group")

 

Director / PDMR Shareholdings

 

Walker Crips Group plc announces that on 26 November 2024, the Trustees of Walker Crips' Share Incentive Plan (the "Plan") completed the acquisition of 61,366 ordinary shares (comprising of 30,683 Partnership and 30,683 Matching shares) for the benefit of the participants of the Plan. The price paid by the participants was 18.40p. The Partnership shares will be used to satisfy employees' contributions to the Plan deducted from their November salary. The Matching shares are purchased for the employees' benefit by the Group and are subject to certain eligibility criteria. 

 

David Gelber acquired 811 Partnership shares under the Share Incentive Plan, giving him a total of 201,759 shares held under the Plan.

 

For further information contact

 

Walker Crips Group Plc

Rod Goddard, Company Secretary +44 (0) 20 3100 8000

 

Singer Capital Markets

Charles Leigh-Pemberton / Asha Chotai +44 (0) 20 7496 3000

 

The person responsible for arranging the release of this information is Sanath Dandeniya, Finance Director of the Company.

 

The following notification is intended to satisfy the Company's obligations under Article 19(3) of EU Regulation No 596/2014 (the Market Abuse Regulation)

 

1.

Details of the person discharging managerial responsibilities / person closely associated

a)

Name

David Gelber

2.

Reason for the Notification

a)

Position/status

Non-Executive Director

b)

Initial notification/Amendment

Initial 

3.

Details of the issuer, emission allowance market participant, auction platform, auctioneer or auction monitor

a)

Name

WALKER CRIPS GROUP PLC

b)

LEI

213800T71F7VD5ANZI55

4.

Details of the transaction(s): section to be repeated for (i) each type of instrument; (ii) each type of transaction; (iii) each date; and (iv) each place where transactions have been conducted

a)

Description of the Financial instrument, type of instrument

Ordinary shares of 6 2/3 pence each

Identification code

GB00B1YMRV88

b)

Nature of the transaction

PURCHASE OF SHARES TO GO INTO SHARE INCENTIVE PLAN (SIP)

c)

Price(s) and volume(s)

Price(s)

18.40p

Volume(s)

811 Shares

d)

Aggregated information:

· Aggregated volume

· Price

N/A Single transaction

e)

Date of the transaction

26/11/2024

f)

Place of the transaction

London Stock Exchange(XLON)

 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
 
END
 
 
DSHFIFFDLSLDFIS
Date   Source Headline
31st Jul 20204:00 pmRNSAppointment of Broker
31st Jul 20203:47 pmRNSFinal Results
15th Jun 20207:00 amRNSDirector/PDMR Shareholding
24th Dec 201911:15 amRNSDirector/PDMR Shareholding
27th Nov 20197:00 amRNSHalf-year Report
26th Nov 201912:55 pmRNSDirector/PDMR Shareholding
13th Nov 20193:05 pmRNSDirector/PDMR Shareholding
3rd Oct 201912:12 pmRNSDirector/PDMR Shareholding
2nd Oct 20192:05 pmRNSSecond Price Monitoring Extn
2nd Oct 20192:00 pmRNSPrice Monitoring Extension
24th Sep 20197:00 amRNSManagement Changes
23rd Sep 20194:30 pmRNSDirector/PDMR Shareholding
4th Sep 20193:00 pmRNSResult of AGM
4th Sep 20198:30 amRNSBoard Changes
22nd Aug 20199:30 amRNSDirector/PDMR Shareholding
31st Jul 20195:19 pmRNSDirector/PDMR Shareholding
31st Jul 201910:20 amRNSDirector/PDMR Shareholding
29th Jul 20192:40 pmRNSDirector/PDMR Shareholding
11th Jul 201912:03 pmRNSFinal Results
27th Jun 20195:20 pmRNSDirector/PDMR Shareholding
29th May 201912:01 pmRNSDirector/PDMR Shareholding
21st May 20195:15 pmRNSDirector/PDMR Shareholding
8th May 201911:30 amRNSDirector/PDMR Shareholding
27th Mar 20196:30 pmRNSDirector/PDMR Shareholding
13th Mar 20195:53 pmRNSReplacement Director/PDMR Shareholding
13th Mar 201912:53 pmRNSDirector/PDMR Shareholding
7th Mar 20194:52 pmRNSDirector/PDMR Shareholding
4th Mar 20198:44 amRNSDirector/PDMR Shareholding
1st Mar 20193:56 pmRNSDirector/PDMR Shareholding
26th Feb 20194:00 pmRNSTrading Update
12th Feb 20194:56 pmRNSDirector / PDMR Shareholdings
30th Jan 20197:00 amRNSBoard changes
17th Dec 201812:00 pmRNSDirector/PDMR Shareholding
27th Nov 20188:36 amRNSHalf-year Report - Replacement
27th Nov 20187:00 amRNSResults for the six months ended 30 September 2018
29th Oct 201811:25 amRNSDirector/PDMR Shareholding
11th Oct 20182:53 pmRNSDirector/PDMR Shareholding
20th Sep 201811:10 amRNSDirector/PDMR Shareholding
14th Sep 20185:24 pmRNSDirector/PDMR Shareholding
5th Sep 20184:33 pmRNSResult of AGM
31st Jul 20184:08 pmRNSFinal Results
8th Jun 20183:28 pmRNSDirector/PDMR Shareholding
25th May 20187:00 amRNSIssue of Equity and Total Voting Rights
26th Apr 20188:20 amRNSHolding(s) in Company
18th Apr 20185:34 pmRNSDirector/PDMR Shareholding
21st Mar 20187:00 amRNSHolding(s) in Company
6th Mar 20185:36 pmRNSHolding(s) in Company
19th Feb 20183:30 pmRNSDirector/PDMR Shareholding
9th Feb 20184:55 pmRNSDirectorate Change
4th Jan 201810:10 amRNSDirector/PDMR Shareholding

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.